Clinical trials are specialized studies that evaluate treatments and procedures to determine whether they’re safe and effective in humans. Eye Treatment Center is an independent research facility that conducts or participates in clinical trials in ophthalmology, neurology, and psychiatry.
Clinical trials have four separate phases, along with phase 0 for the very earliest research.
In phase I, the doctors test a drug in a small number of patients using low doses. The main focus of a phase I trial is finding the ideal dose with the fewest side effects.
In phase II, more patients participate in testing, and the dosage is generally kept the same.
In phase III, a large group of patients takes the new medication. This is a long phase, in many cases lasting for a few years. The phase III trial focuses on evaluating the effectiveness of the new drug in relation to existing treatments. To move to the final phase, the new drug must show benefits equal to or exceeding those of the existing drugs.
Phase IV, the final phase, takes place after the drug has been granted approval by the FDA. Phase IV trials can last a very long time because the main goal is to evaluate long-term safety and effectiveness.
Eye Treatment Center conducts clinical trials including phase I, II, III, and IV. The team’s goal is to obtain quality research data for sponsors while offering patients unique cutting-edge treatment opportunities.
Eye Treatment Center regularly conducts clinical trials for a wide range of medications. If your doctor determines that you’re a good potential candidate for a clinical trial during an eye exam, they explain the opportunity to you and discuss the process in detail so you can decide if it’s right for you. You may also see one of our doctors if you are participating in a clinical trial and there are ophthalmological safety protocols included in the trial.
Call Eye Treatment Center or book an appointment with online scheduling to learn more about the current clinical trials now.